Inclusion Criteria:  Caucasian subjects of female sex, 20-60 years old, phototype I-IV according to Fitzpatrick skin type classification and in good general health. Subjects with sensitive skin (positive reaction to stinging test, score ≥ 3). Subjects suffering from persistent centrofacial erythema of rosacea with no more than 3 papules and pustules. Subjects able to follow all study directions and willing to commit to all follow-up visits for the duration of the study. Subjects who have completed the written informed consent process. Subjects who avoid the exposure to UV radiation and the use of tanning beds for the duration of the study.  Exclusion Criteria:  Pregnant or nursing females. Subjects with Rosacea and more than 3 papules or pustules. Subjects who are taking topical or systemic drugs that could affect the results of the test (immunosuppressants, anti-inflammatory agents, corticosteroids, etc.). Subjects with a change in contraception. Subjects showing systemic diseases or skin disorders (such as eczema, psoriasis, severe acne, etc.) that may affect the evaluation of the test articles or increase risk to the subject. Subjects who have used treatments for rosacea (either topical and/or systemic) within a period of 30 days prior to admission in this study. Subjects who have been involved in another clinical investigation with comparable purposes within a period of 30 days prior to admission in this study.